Tolerance mechanisms of allergen immunotherapy

被引：28
|
作者：
van de Veen, Willem [1 ,2 ]
Akdis, Muebeccel [1 ]
机构：
[1] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland
[2] CK CARE, Davos, Switzerland
来源：
ALLERGY | 2020年 / 75卷 / 05期
基金：
瑞士国家科学基金会;
关键词：
CELLS;
D O I：
10.1111/all.14126
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1017 / 1018
页数：2
相关论文
共 50 条
  • [31] An evidence-based appraisal of the surrogate markers of efficacy of allergen immunotherapy
    Senna, Gianenrico
    Calderon, Moises
    Makatsori, Melina
    Ridolo, Erminia
    Passalacqua, Giovanni
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (04) : 375 - 380
  • [32] Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
    Jakwerth, Constanze A.
    Kitzberger, Hannah
    Pogorelov, Dimitrii
    Mueller, Annika
    Blank, Simon
    Schmidt-Weber, Carsten B.
    Zissler, Ulrich M.
    FRONTIERS IN ALLERGY, 2022, 3
  • [33] Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy
    Floch, Veronique Bordas-Le
    Berjont, Nathalie
    Batard, Thierry
    Varese, Nirupama
    O'Hehir, Robyn E.
    Canonica, Walter G.
    van Zelm, Menno C.
    Mascarell, Laurent
    ALLERGY, 2022, 77 (04) : 1263 - 1273
  • [34] Effect of allergen-specific immunotherapy on CD4+ T cells
    Wambre, Erik
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 15 (06) : 581 - 587
  • [35] Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis
    Worm, Margitta
    Pfaar, Oliver
    ALLERGOLOGIE SELECT, 2023, 7 : 84 - 89
  • [36] Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy
    Mitobe, Yuko
    Yokomoto, Yasuki
    Ohashi-Doi, Katsuyo
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 71 (03) : 529 - 540
  • [37] Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge
    Scadding, G. W.
    Eifan, A. O.
    Lao-Araya, M.
    Penagos, M.
    Poon, S. Y.
    Steveling, E.
    Yan, R.
    Switzer, A.
    Phippard, D.
    Togias, A.
    Shamji, M. H.
    Durham, S. R.
    ALLERGY, 2015, 70 (06) : 689 - 696
  • [38] Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy
    Fonseca, D. M.
    Wowk, P. F.
    Paula, M. O.
    Gembre, A. F.
    Baruffi, M. D.
    Fermino, M. L.
    Turato, W. M.
    Campos, L. W.
    Silva, C. L.
    Ramos, S. G.
    Horn, C.
    Marchal, G.
    Arruda, L. K.
    Russo, M.
    Bonato, V. L. D.
    ALLERGY, 2015, 70 (03) : 275 - 284
  • [39] Prophylactic use of sublingual allergen immunotherapy in high-risk children: A pilot study
    Holt, Patrick G.
    Sly, Peter D.
    Sampson, Hugh A.
    Robinson, Phil
    Loh, Richard
    Lowenstein, Henning
    Calatroni, Agustin
    Sayre, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (04) : 991 - 993
  • [40] Identification of key genes and the pathophysiology associated with allergen-specific immunotherapy for allergic rhinitis
    Fan, Kai
    Zhou, Shican
    Jin, Ling
    Tan, Shiwang
    Lai, Ju
    Zhang, Zimu
    Li, Jingwen
    Xu, Xiayue
    Yao, Chunyan
    Yan, Zhiqiang
    Yu, Shaoqing
    BMC IMMUNOLOGY, 2023, 24 (01)
12345